Hepatitis C virus nonstructural protein 5A inhibits tumor necrosis factor-α-mediated apoptosis in Huh7 cells

被引:18
作者
Miyasaka, Y
Enomoto, N
Kurosaki, M
Sakamoto, N
Kanazawa, N
Kohashi, T
Ueda, E
Maekawa, S
Watanabe, H
Izumi, N
Sato, C
Watanabe, M
机构
[1] Tokyo Med & Dent Univ, Dept Gastroenterol & Hepatol, Bunkyo Ku, Tokyo 1138519, Japan
[2] Tokyo Med & Dent Univ, Dept Analyt Hlth Sci, Bunkyo Ku, Tokyo 1138519, Japan
[3] Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan
关键词
D O I
10.1086/379253
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To analyze the influence of hepatitis C virus nonstructural protein 5A ( NS5A) on apoptosis, we established Huh7 cells that stably express NS5A, and induced apoptosis using tumor necrosis factor ( TNF) - alpha. The viability of control Huh7 cells was reduced to 40%, compared with untreated cells, after TNF- alpha treatment, whereas that of Huh7- NS5A cells was reduced only to 80%. DNA fragmentation also decreased to < 50% in Huh7-NS5A compared with control cells. Nuclear factor - κB activation was the same in both cell types, whereas caspase- 8, - 9, and - 3 activity was decreased in Huh7- NS5A cells, compared with control cells, which indicates that the inhibition of caspase- 8 activation is responsible for the antiapoptotic effect of the NS5A protein. The coexpression of NS5A did not inhibit apoptosis induced by caspase- 8 or Fas- associating death domain protein expression. These findings suggest that the NS5A protein inhibits the apoptotic effect of TNF- α upstream of caspase- 8 in the apoptosis cascade.
引用
收藏
页码:1537 / 1544
页数:8
相关论文
共 51 条
[11]   The interferon-induced protein kinase (PKR), triggers apoptosis through FADD-mediated activation of caspase 8 in a manner independent of Fas and TNF-α receptors [J].
Gil, J ;
Esteban, M .
ONCOGENE, 2000, 19 (32) :3665-3674
[12]   Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-κB [J].
Gong, GZ ;
Waris, G ;
Tanveer, R ;
Siddiqui, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (17) :9599-9604
[13]   Noncytolytic control of viral infections by the innate and adaptive immune response [J].
Guidotti, LG ;
Chisari, FV .
ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 :65-91
[14]   Akt protects mouse hepatocytes from TNF-α- and Fas-mediated apoptosis through NK-κB activation [J].
Hatano, E ;
Brenner, DA .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2001, 281 (06) :G1357-G1368
[15]   Course and outcome of hepatitis C [J].
Hoofnagle, JH .
HEPATOLOGY, 2002, 36 (05) :S21-S29
[16]   TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways [J].
Hsu, HL ;
Shu, HB ;
Pan, MG ;
Goeddel, DV .
CELL, 1996, 84 (02) :299-308
[17]   Serum levels of soluble tumor necrosis factor receptors and effects of interferon therapy in patients with chronic hepatitis C virus infection [J].
Itoh, Y ;
Okanoue, T ;
Ohnishi, N ;
Sakamoto, M ;
Nishioji, K ;
Nakagawa, Y ;
Minami, M ;
Murakami, Y ;
Kashima, K .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (05) :1332-1340
[18]   Serum levels of IL-10, IL-15 and soluble tumour necrosis factor-alpha (TNF-alpha) receptors in type C chronic liver disease [J].
Kakumu, S ;
Okumura, A ;
Ishikawa, T ;
Yano, M ;
Enomoto, A ;
Nishimura, H ;
Yoshioka, K ;
Yoshikai, Y .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 109 (03) :458-463
[19]  
Kallinowski B, 1998, CLIN EXP IMMUNOL, V111, P269
[20]   The burden of hepatitis C in the United States [J].
Kim, WR .
HEPATOLOGY, 2002, 36 (05) :S30-S34